{"id":"W4295828289","doi":"10.1016/j.annonc.2022.07.1314","title":"1191TiP Nivolumab-ipilimumab with cfDNA-guided treatment intensification as a chemotherapy-sparing strategy in metastatic non-small cell lung cancer (ATLAS)","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Oncology; Internal medicine; Chemotherapy; Lung cancer; Atlas (anatomy); Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000158459,0.0001620854,0.0002867343,0.0003040655,0.0002048184,0.0005935522,0.0002996603,0.0002745154,0.009827089],"category_scores_gemma":[0.0002586786,0.00008814695,0.0003800144,0.0003616719,0.0001063293,0.0002117507,0.0001775903,0.0003880321,0.001600206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001114181,"about_ca_system_score_gemma":0.0008857716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004849412,"about_ca_topic_score_gemma":0.01496063,"domain_scores_codex":[0.99993,0.00001322536,0.000004524053,0.00001598617,0.00001653454,0.0000196517],"domain_scores_gemma":[0.9999396,0.00001180132,0.000006428223,0.000005901265,0.00001568687,0.00002053047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.005827096,0.0002926517,0.02109008,0.0009057331,0.0003491504,0.0008398195,0.00007784009,0.003088512,0.02064529,0.002455238,0.1676227,0.7768059],"study_design_scores_gemma":[0.005354109,0.003360592,0.1905978,0.0006317667,0.001390319,0.008995222,0.0001671429,0.01402884,0.02849006,0.005446842,0.7414562,0.00008111414],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.652481,0.0756307,0.009292915,0.02161959,0.003835222,0.0007247935,0.03264482,0.003828468,0.1999425],"genre_scores_gemma":[0.9122815,0.01670857,0.01422732,0.005269278,0.0007492097,0.0003425742,0.01663052,0.0002855073,0.03350559],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009827089,"threshold_uncertainty_score":0.03287482,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04558093756363332,"score_gpt":0.3399214523671793,"score_spread":0.294340514803546,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}